Abstract
Serotype replacement in Streptococcus pneumoniae following the implementation of a new vaccine has been associated with the emergence of non-vaccine serotypes as prominent causes of invasive pneumococcal disease (IPD). The aim of this study was to characterize specific non-PCV-13 serotypes 15A, 22F, 33F and 35B from IPD, isolated in Canada post-PCV-13 introduction in 2010. Of 3802 IPD isolates collected from across Canada in 2011-13, 18.4% were found to be serotypes 15A, 22F, 33F and 35B. These 699 isolates were subjected to antimicrobial susceptibility testing, PFGE, MLST, molecular detection of pneumococcal pili and comparison with Pneumococcal Molecular Epidemiology Network (PMEN) clones. This study demonstrated clonal spread of specific STs, including MDR ST63 and its Sweden(15A)-25-related variants, the increasingly common ST433 and a variant of piliated, penicillin-non-susceptible ST558, related to PMEN clone Utah(35B)-24 (ST377). New STs of serotype 33F were identified. Several potential capsular switching events were identified within these serotypes. Non-PCV-13 serotype 22F is increasing in Canada through the rapid clonal expansion of ST433. Numerous new STs associated with serotype 33F indicate the potential divergenc...Continue Reading
References
Mar 9, 1999·The Journal of Infectious Diseases·M LouieA E Simor
Sep 9, 2000·The Journal of Infectious Diseases·R Sá-LeãoH de Lencastre
Feb 17, 2006·Proceedings of the National Academy of Sciences of the United States of America·M A BarocchiB Henriques-Normark
Nov 21, 2007·PLoS Pathogens·Angela B BrueggemannBernard Beall
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra S RichterGary V Doern
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Feb 24, 2010·The Journal of Infectious Diseases·Robert E GertzUNKNOWN Active Bacterial Core Surveillance Team
May 4, 2010·Vaccine·Gili Regev-YochayRichard Malley
May 29, 2010·Emerging Infectious Diseases·Dorothea ZähnerDavid S Stephens
Oct 4, 2011·Vaccine·Julie M SkinnerJon H Heinrichs
Dec 30, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Heather J AdamGeorge G Zhanel
Jul 26, 2012·Canadian Journal of Microbiology·Walter H B DemczukUNKNOWN Canadian Public Health Laboratory Network
Dec 28, 2012·Journal of Clinical Microbiology·Bruno PichonRobert George
Oct 9, 2013·The Medical Journal of Australia·Janet E StrachanGeoffrey G Hogg
Citations
Feb 26, 2016·New Microbes and New Infections·M KawaguchiyaN Kobayashi
Apr 14, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Venkata R DuvvuriJonathan B Gubbay
Apr 17, 2016·Vaccine·Alyssa R GoldenUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)
Jun 22, 2016·Vaccine·Carina ValenteRaquel Sá-Leão
Nov 17, 2016·Journal of Clinical Microbiology·Liset OlarteKristina G Hultén
Jul 15, 2015·Antimicrobial Agents and Chemotherapy·Martha McElligottHilary Humphreys
Jan 26, 2018·Current Infectious Disease Reports·Nicola PrincipiSusanna Esposito
Sep 27, 2019·Pathogens·Mitsuyo KawaguchiyaNobumichi Kobayashi
Jul 10, 2018·The Journal of Antimicrobial Chemotherapy·Alyssa R GoldenUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)
Jan 14, 2017·Frontiers in Microbiology·Xianding DengJonathan B Gubbay
May 19, 2017·Emerging Infectious Diseases·Sopio ChochuaBernard Beall
Sep 23, 2021·Microbial Genomics·Akuzike Kalizang'omaRobert S Heyderman